Article thumbnail
Location of Repository

Association of Toll-Like Receptor Signaling and Reactive Oxygen Species: A Potential Therapeutic Target for Posttrauma Acute Lung Injury

By Meng Xiang, Janet Fan and Jie Fan


Acute lung injury (ALI) frequently occurs in traumatic patients and serves as an important component of systemic inflammatory response syndrome (SIRS). Hemorrhagic shock (HS) that results from major trauma promotes the development of SIRS and ALI by priming the innate immune system for an exaggerated inflammatory response. Recent studies have reported that the mechanism underlying the priming of pulmonary inflammation involves the complicated cross-talk between Toll-like receptors (TLRs) and interactions between neutrophils (PMNs) and alveolar macrophages (AMϕ) as well as endothelial cells (ECs), in which reactive oxygen species (ROS) are the key mediator. This paper summarizes some novel mechanisms underlying HS-primed lung inflammation focusing on the role of TLRs and ROS, and therefore suggests a new therapeutic target for posttrauma ALI

Topics: Review Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2005). A .T s u n g ,R .A .H o ffman, K. Izuishi et al., “Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells,”
  2. (1983). a i s t ,A .E .B a u e ,H .D i t t m e r ,a n dG .H e b e r e r ,“ M u l t i p l e organ failure in polytrauma patients,”
  3. (2002). a n ,R .S .F r e y ,A .R a h m a n ,a n dA .B .M a l i k ,“ R o l eo f neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-α-induced NF-κB activation and intercellular adhesion molecule-1 expression in endothelial cells,”
  4. (1997). A trial of antioxidants N-acetylcysteine and procysteine in ARDS.
  5. (1983). A.A.Fowler,R.F.Hamman,andJ.T.Good,“Adultrespiratory distresssyndrome:riskwithcommonpredispositions,”Annals of Internal Medicine,
  6. (2007). A.Tsung,J.R.Klune,X.Zhangetal.,“HMGB1releaseinduced by liver ischemia involves Toll-like receptor 4-dependent reactive oxygen species production and calcium-mediated signaling,”
  7. (1967). Acute respiratory distress in adults,”
  8. (2000). Akg¨ u r ,M .F .B r o w n ,G .B .Z i b a r ie ta l . ,“ R o l eo fs u p e r -oxide in hemorrhagic shock-induced P-selectin expression,”
  9. (2006). Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock,”
  10. (2000). Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway,”
  11. (2004). Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway,”
  12. (2002). Deaths: leading causes for
  13. (2006). Details of Toll-like receptor: adapter interaction revealed by germ-line mutagenesis,”
  14. (2001). Differential expression of Toll-like receptor 2 in human cells,”
  15. (2006). Ding et al., “HMGB1 signals through tolllikereceptor(TLR)4andTLR2,”Shock,vol.26,no.2,pp.174– 179,
  16. (1998). Does N-acetyl-L-cysteine influence cytokine response during early human septic shock?”
  17. (2003). e h n e r t ,G .E .A r t e e l ,O .M .S m u t n e ye ta l . ,“ D e p e n d e n c e of liver injury after hemorrhage/resuscitation in mice on NADPH oxidase-derived superoxide,”
  18. (1994). Early predictors of postinjury multiple organ failure,”
  19. (2003). Endotheliumderived toll-likereceptor-4isthekey molecule in LPS-induced neutrophil sequestration into lungs,”
  20. (1999). Endotoxintolerant mice have mutations in toll-like receptor 4
  21. (1995). Evolving concepts in the pathogenesis of postinjury multiple organ failure,”
  22. (2009). Fant` o et al., “Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases,”
  23. (2007). Fant` o et al., “Pivotal Advance: inhibition of MyD88 dimerization and recruitment of IRAK1 and IRAK4 by a novel peptidomimetic compound,”
  24. (2001). Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4,”
  25. (2009). Hemorrhagic shock augments lung endothelial cell activation: role of temporal alterations of TLR4 and TLR2,”
  26. (2007). Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling,”
  27. (1998). Hemorrhagic shock primes for increased expression of cytokine-induced neutrophil chemoattractant in the lung: role in pulmonary inflammation following lipopolysaccharide,”JournalofImmunology,vol.161,no.1,pp. 440–447,
  28. (2006). Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation,”AmericanJournalofPhysiology,vol.290,no.4,pp.L738– L746,
  29. (2006). High mobility group box 1 protein interacts with multiple Toll-like receptors,”
  30. (2005). High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal,”
  31. (2009). HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans,”
  32. (2002). HSP70 as endogenous stimulus of the toll/interleukin-1 receptor signal pathway,”
  33. (2007). Inflammasomes in inflammatory disorders: the role of TLRs and their interactions with NLRs,”
  34. (2005). Inhibitors of NADPH oxidase reduce the organ injury in hemorrhagic shock,”
  35. (2009). Interacting neuroendocrine and innate and acquired immune pathways regulate neutrophil mobilization from bone marrow following hemorrhagic shock,”
  36. (2004). Involvement of Tolllike receptors 2 and 4 in cellular activation by high mobility group box 1 protein,”
  37. (2001). L .I m l e ra n dJ .A .H o ffmann,
  38. (2002). Lipopolysaccharide-induced leukocyte-endothelial cell interactions: a role for CD14 versus toll-like receptor 4 within microvessels,”
  39. (1994). N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study,”
  40. (1991). N-acetylcysteine in experimental and clinical acute lung injury,”
  41. (1999). NADPH oxidase: an update,”
  42. (1987). Neutrophil kinetics and lunginjury,”Physiological Reviews,
  43. (2007). Neutrophil NAD(P)H oxidase is required for hemorrhagic shock-enhanced TLR2 up-regulation in alveolar macrophages in response to
  44. (1991). Neutrophils and adult respiratorydistresssyndrome:twointerlockingperspectivesin
  45. (2004). NK cells and polymorphonuclear neutrophils are both critical for IL-2-induced pulmonary vascular leak syndrome,”
  46. (2002). Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4,”
  47. (2003). Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension,”
  48. (1979). P r e s c o t t ,R .N .I l l i n g w o r t h ,a n dJ .A .J .H .C r i t c h l e y , “Intravenous N-acetylcysteine: the treatment of choice for paracetamol poisoning,”
  49. (2005). Peptide-mediated interference of TIR domain dimerization in MyD88 inhibits interleukin-1-dependent activation of NF-κB,”
  50. (1997). Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality,”
  51. (1995). Postinjury neutrophil priming and activation: an early vulnerable window,”
  52. (1993). Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes,”
  53. (2002). Randomized, prospective trial of antioxidant supplementation
  54. (1992). Reactive oxygen metabolites in inflammation,” Sbornik Vedeckych Praci Lekarske Fakulty Karlovy University v Hradci Kralove,
  55. (2001). Reactive oxygen species as mediators in asthma,”
  56. (2009). Recent trends in acute lung injury mortality: 1996–2005,” Critical Care Medicine,
  57. (2003). Receptor ”cross talk” in innate immunity,”
  58. (2002). Receptor-mediatedmonitoringoftissuewell-beingviadetection of soluble heparan sulfate by toll-like receptor 4,”
  59. (2002). Regulation of toll-like receptor4expressioninthelungfollowinghemorrhagicshock and lipopolysaccharide,”
  60. (2003). Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway,”
  61. (2000). Role of NAD(P)H oxidase in the tamoxifen-induced generation of reactive oxygen species and apoptosis
  62. (2008). Role of toll-like receptors in the development of sepsis,”
  63. (2003). Rushmere et al., “Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk,”
  64. (2008). Salvage of nonischemic control lung from injury by unilateral ischemic lung with apocynin, a nicotinamide adenine dinucleotide phosphate (NADPH) oxidase inhibitor, in isolated perfused rat lung,”
  65. (2005). SIGIRR inhibits interleukin-1 receptor- and Toll-like receptor 4-mediated signaling through different mechanisms,”
  66. (2008). Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrow-derived cells and parenchymal cells,”
  67. (2007). Targeting toll-like receptors for drug development: a summary of commercial approaches,”
  68. (2007). The family of five: TIRdomain-containing adaptors in Toll-like receptor signalling,”
  69. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemiareperfusion,”
  70. (2002). Tissue expression of human Toll-like receptors and differential regulation of Tolll i k er e c e p t o rm R N A si nl e u k o c y t e si nr e s p o n s et om i c r o b e s , their products, and cytokines,”
  71. (2010). TLR cross-talk mechanism of hemorrhagic shockprimed pulmonary neutrophil infiltration,”
  72. (2006). TLR4 gene dosage contributes to endotoxin-induced acute respiratory inflammation,”
  73. (2003). TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase,”
  74. (2006). TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity,”
  75. (2006). Toll-Like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock,”
  76. (2001). Toll-like receptors and innate immunity,”
  77. (2009). Toll-like receptors as targets in chronic liver diseases,”
  78. (2001). Toll-like receptors: critical proteins linking innate and acquired immunity,”
  79. (2004). Toll-like receptors: function and roles in lung disease,”

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.